J Jefferson P Perry

9PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 23, 2026
Second-Generation AOH1996 Analogues with Enhanced Pharmacological Properties for Targeting PCNA.

|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|Jun 05, 2026
Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

|Apr 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer.

|Apr 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growth.

Melissa Valerio, Wenyuan Wei, Hyunjun Kang

|Dec 02, 2025
Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis.

Kai Zhang, Alyssa Ayala, Ignacio Norambuena-Soto

Pageof 2

Frequent Collaborators

2 joint publications

Le Xuan Truong Nguyen

2 joint publications

Chun-Wei David Chen

2 joint publications

Guido Marcucci

2 joint publications

Bin Zhang